PANCREAS CANCER
Clinical trials for PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough-to-treat pancreatic cancer? early trial tests combo approach
Disease control TerminatedThis early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) is safe and effective for people with metastatic pancreatic cancer. Only 4 participants were enrolled before the study was stopped. The goal was to find the right dose …
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC